Zimmer Biomet (ZBH) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Sale Kevin R. Thornal, Grp Pres-Global Business sold 5,691 shares at $92.95 ($529K).
- Trade date
- Sep 11, 2026
- Disclosed to the SEC
- Sep 15, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All ZBH insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
ZBH insider transactions (Form 4)
Open-market purchases and sales. 68 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 15SEC | Kevin R. ThornalGrp Pres-Global Business | Sell | 5,691 | $92.95 | $529K | +10.1% | — |
| Sep 9SEC | Chad F. PhippsSee Remarks Below. | Sell | 3,00065,231 held (−4%) | $98.35 | $295K | +4.0% | — |
| Jun 2SEC | Sang YiPresident | Sell | 4,20028,051 held (−13%) | $82.64 | $347K | +23.8% | — |
| Jun 2SEC | Sang YiPresident | Sell | 80027,251 held (−3%) | $82.66 | $66K | +23.8% | — |
| Mar 16SEC | Lori WinklerSvp And Chro | Sell | 2,65010,224 held (−21%) | $94.66 | $251K | +8.1% | — |
| Feb 17SEC | Sang YiPresident | Sell | 1,00017,670 held (−5%) | $96.49 | $96K | +6.1% | — |
Similar past setups: not applicable. ZBH has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with ZBH in the Research Lab
ZBH has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Zimmer Biomet insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $1.6M of ZBH stock on the open market; P/E 30.2 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
ZBH insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $824K | 2 |
| Q2 2026 | — | 0 | $413K | 2 |
| Q1 2026 | — | 0 | $347K | 2 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Zimmer Biomet insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $1.6M. 0 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ZBH earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 5, 2026 | +6.8% | None | +1.4%S&P -0.4% | +0.9% |
| Apr 28, 2026 | -0.6% | None | -13.5%S&P -0.5% | +2.8% |
| Feb 10, 2026 | +3.6% | None | +6.6%S&P -0.3% | -2.5% |
| Nov 5, 2025 | +0.4% | None | -14.2%S&P -0.7% | +6.5% |
| Aug 7, 2025 | -5.6% | None | +8.9%S&P +0.7% | +6.5% |
| May 5, 2025 | +4.6% | None | -9.9%S&P -1.4% | -0.4% |
| Feb 6, 2025 | -2.1% | None | -6.8%S&P -0.6% | +7.0% |
| Oct 30, 2024 | -0.9% | None | +2.9%S&P -2.3% | +4.8% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
ZBH short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded ZBH
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +16.5% |
Insiders at Zimmer Biomet
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Kevin R. ThornalGrp Pres-Global Business | — | $529K | Sep 15, 2026 | — | — |
| Sang YiPresident | — | $510K | Jun 2, 2026 | — | — |
| Chad F. PhippsSee Remarks Below. | — | $295K | Sep 9, 2026 | — | — |
| Lori WinklerSvp And Chro | — | $251K | Mar 16, 2026 | — | — |
| Gary Craig CampbellPresident | — | — | Oct 5, 2026 | — | — |
| Jehanzeb NoorSee Remarks Below. | — | — | Apr 3, 2026 | — | — |
| Ivan TornosCEO, President | — | — | Mar 10, 2026 | — | — |
| Suketu UpadhyayCFO | — | — | Mar 10, 2026 | — | — |
| Zuilen Wilfred VanGroup Pres, Emea | — | — | Mar 10, 2026 | — | — |
| Paul A. StellatoVp, Controller, Cao | — | — | Mar 10, 2026 | — | — |
Board links: companies that share insiders with ZBH
Directors and executives who filed Form 4s for ZBH and another company in the last 12 months.
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
ZBH stock: common questions
Are Zimmer Biomet insiders buying ZBH stock?
No. No Zimmer Biomet insider reported an open-market purchase of ZBH in the past 12 months.
Are Zimmer Biomet insiders selling ZBH stock?
4 insiders reported sales worth $1.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ZBH's P/E ratio?
ZBH trades at about 30.2 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is ZBH's 52-week range?
Over the past year ZBH has traded between $79.16 and $110.15. It last closed at $102.33 on Nov 19, 2026.